{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:14:58Z","timestamp":1792818898803,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T00:00:00Z","timestamp":1436313600000},"content-version":"vor","delay-in-days":372,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jacc.2014.05.003","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T15:45:13Z","timestamp":1404315913000},"page":"83-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":593,"title":["Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"64","author":[{"given":"Barry J.","family":"Maron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve R.","family":"Ommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Semsarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Spirito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2014.05.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/hrt.20.1.1","article-title":"Asymmetric hypertrophy of the heart in young adults","volume":"20","author":"Teare","year":"1958","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacc.2014.05.003_bib2","first-page":"3","article-title":"Idiopathic hypertrophic subaortic stenosis. I. A\u00a0description of the disease based upon an analysis of 64 patients","volume":"30","author":"Braunwald","year":"1964","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.CIR.26.2.161","article-title":"Hypertrophic subaortic stenosis\u2014a broadened concept","volume":"26","author":"Braunwald","year":"1962","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.05.003_bib5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM199703133361107","article-title":"The management of hypertrophic cardiomyopathy","volume":"336","author":"Spirito","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.05.003_bib6","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.05.003_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amjmed.2003.10.012","article-title":"Hypertrophic cardiomyopathy: an\u00a0important global disease","volume":"116","author":"Maron","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2014.05.003_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.109.878579","article-title":"Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy","volume":"121","author":"Maron","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","article-title":"Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance","volume":"54","author":"Maron","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/CIRCULATIONAHA.107.691378","article-title":"Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"116","author":"Maron","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jacc.2008.11.069","article-title":"The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy","volume":"54","author":"Maron","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2012.02.068","article-title":"Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives","volume":"60","author":"Maron","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib13","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.jacc.2004.04.063","article-title":"The case for surgery in obstructive hypertrophic cardiomyopathy","volume":"44","author":"Maron","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","article-title":"Clinical course of hypertrophic cardiomyopathy in a regional United States cohort","volume":"281","author":"Maron","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.05.003_bib15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","article-title":"Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population","volume":"102","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib16","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represents a primary phenotypic expression of hypertrophic cardiomyopathy","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib19","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib20","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.05.003_bib22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.84.3.1188","article-title":"Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction","volume":"84","author":"Klues","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib23","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jacc.2004.08.052","article-title":"Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy","volume":"44","author":"Maron","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.amjcard.2010.10.022","article-title":"Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy","volume":"107","author":"Maron","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCRESAHA.110.223834","article-title":"Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history","volume":"108","author":"Seidman","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2014.05.003_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0735-1097(01)01386-9","article-title":"Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein-C gene mutations","volume":"38","author":"Maron","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.05.003_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.05.003_bib29","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2013.01.037","article-title":"Prevention of sudden cardiac death with the implantable cardioverter-defibrillator in children and adolescents with hypertrophic cardiomyopathy","volume":"61","author":"Maron","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCHEARTFAILURE.112.969626","article-title":"Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Schinkel","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2014.05.003_bib31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ahj.2013.06.009","article-title":"Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications","volume":"166","author":"Vriesendorp","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.05.003_bib32","article-title":"A\u00a0novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)","author":"O'Mahony","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.05.003_bib33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/heartjnl-2012-303271","volume":"99","author":"O'Mahony","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2014.05.003_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/europace\/eup431","article-title":"Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers","volume":"12","author":"Christiaans","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2014.05.003_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with\u00a0hypertrophic cardiomyopathy","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib36","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib37","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.111.076257","article-title":"Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"126","author":"Sorajja","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy over 60 years of age","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib39","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"Maron","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib40","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib41","first-page":"A13294","article-title":"Evidence for reduced mortality in an adult cohort with hypertrophic cardiomyopathy","volume":"128","author":"Rowin","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib42","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.112.123174","article-title":"Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease","volume":"126","author":"Maron","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Assessment of the prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib44","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0735-1097(02)02976-5","article-title":"Relationship of race to sudden cardiac death in\u00a0competitive athletes with hypertrophic cardiomyopathy","volume":"41","author":"Maron","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib46","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.amjcard.2006.07.029","article-title":"Determinants for clinical diagnosis of hypertrophic cardiomyopathy","volume":"98","author":"Adabag","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib47","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jcmg.2009.03.022","article-title":"Identification of unexpected nonatherosclerotic cardiovascular disease with CT angiography","volume":"2","author":"Knickelbine","year":"2009","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2014.05.003_bib48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jacc.2009.02.075","article-title":"Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy","volume":"54","author":"Bos","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib49","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/gim.2013.44","article-title":"Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy","volume":"15","author":"Ingles","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2014.05.003_bib50","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","article-title":"Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy","volume":"338","author":"Niimura","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.05.003_bib51","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/eurheartj\/ehq111","article-title":"Emergence of gene mutation carriers and the expanding disease spectrum of hypertrophic cardiomyopathy","volume":"31","author":"Maron","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.05.003_bib52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijcard.2011.07.095","article-title":"Natural history of genotype positive - phenotype negative patients with hypertrophic cardiomyopathy","volume":"152","author":"Gray","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib53","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/01.CIR.0000019070.70491.6D","article-title":"Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy","volume":"105","author":"Ho","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib54","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.05.003_bib55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCIMAGING.112.972760","article-title":"Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy","volume":"5","author":"Maron","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2014.05.003_bib56","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/eurheartj\/ehr092","article-title":"Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy","volume":"32","author":"Christiaans","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.05.003_bib57","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2005.02.011","article-title":"Task force 4: hypertrophic cardiomyopathy and other cardiomyopathies, mitral valve prolapse, myocarditis and Marfan syndrome","volume":"45","author":"Maron","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib58","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.hrthm.2014.03.017","article-title":"Conveying a probabilistic gene result to families with an inherited heart disease","volume":"11","author":"Ingles","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2014.05.003_bib59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/gim.2013.138","article-title":"Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment","volume":"16","author":"Das","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2014.05.003_bib60","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2009.371","article-title":"Clinical outcome and phenotypic expression in LAMP 2 cardiomyopathy","volume":"301","author":"Maron","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.05.003_bib61","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.amjcard.2011.07.048","article-title":"Onset of apical hypertrophic cardiomyopathy in adulthood","volume":"108","author":"Maron","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib62","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0735-1097(95)00390-8","article-title":"Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients","volume":"26","author":"Klues","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.CIR.47.2.225","article-title":"Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS","volume":"47","author":"Henry","year":"1973","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib64","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.104.507723","article-title":"Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy","volume":"112","author":"Rickers","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib65","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.05.003_bib66","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.amjcard.2007.05.061","article-title":"Right ventricular involvement in hypertrophic cardiomyopathy","volume":"100","author":"Maron","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib67","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2008.04.047","article-title":"Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"52","author":"Olivotto","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacc.2013.03.062","article-title":"Obesity and its association with phenotype and clinical course of hypertrophic cardiomyopathy","volume":"62","author":"Olivotto","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib69","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.amjcard.2011.12.027","article-title":"Hypertrophic cardiomyopathy with longevity into the tenth decade of life","volume":"109","author":"Maron","year":"2012","journal-title":"Am J Cardiol"},{"issue":"Suppl II","key":"10.1016\/j.jacc.2014.05.003_bib70","first-page":"179","article-title":"The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy","volume":"35","author":"Shah","year":"1974","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2014.05.003_bib71","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0140-6736(73)92730-X","article-title":"Prognosis and mortality of hypertrophic obstructive cardiomyopathy","volume":"2","author":"Hardarson","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.05.003_bib72","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/adc.59.10.971","article-title":"Hypertrophic cardiomyopathy: an important cause of sudden death","volume":"59","author":"McKenna","year":"1984","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jacc.2014.05.003_bib73","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM198903233201201","article-title":"Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population","volume":"320","author":"Spirito","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.05.003_bib74","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.amjcard.2009.05.064","article-title":"Hypertrophic cardiomyopathy centers","volume":"104","author":"Maron","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib75","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.amjcard.2013.06.040","article-title":"Contemporary surgical management of hypertrophic cardiomyopathy, the need for more myectomy surgeons and disease-specific centers, and the Tufts initiative","volume":"112","author":"Maron","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib76","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib77","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.amjcard.2014.01.435","article-title":"Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign clinical presentation and without risk factors","volume":"113","author":"Spirito","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib78","first-page":"A16910","article-title":"Can spironolactone mitigate myocardial fibrosis and alter sudden death risk and heart failure symptoms in patients with hypertrophic cardiomyopathy?: A prospective, randomized trial","volume":"128","author":"Maron","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib79","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jacc.2009.04.072","article-title":"The case for myocardial ischemia in hypertrophic cardiomyopathy","volume":"54","author":"Maron","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib80","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.05.003_bib81","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.hrthm.2009.03.014","article-title":"Long-term survival after cardiac arrest in hypertrophic cardiomyopathy","volume":"6","author":"Maron","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2014.05.003_bib82","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.hrthm.2009.02.007","article-title":"Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy","volume":"6","author":"Maron","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2014.05.003_bib83","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/hrt.2008.150656","article-title":"Device complications and inappropriate implantable cardioverter-defibrillator shocks in patients with hypertrophic cardiomyopathy","volume":"95","author":"Lin","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2014.05.003_bib84","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/CIRCULATIONAHA.110.975219","article-title":"Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management","volume":"123","author":"Hauser","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib85","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1161\/01.CIR.0000144463.65977.C9","article-title":"Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient?","volume":"110","author":"Boriani","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib86","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jacc.2012.07.069","article-title":"The subcutaneous implantable cardioverter-defibrillator: should patients want one?","volume":"61","author":"Hauser","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib87","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.108.804617","article-title":"Sudden deaths in young competitive athletes: analysis of 1866 deaths in the U.S., 1980-2006","volume":"119","author":"Maron","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib88","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000025","article-title":"Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in general healthy populations of young people (12-25 years of age)","author":"Maron","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib89","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/eurheartj\/ehq136","article-title":"Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy","volume":"31","author":"Melacini","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.05.003_bib90","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib91","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib92","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/euq013","article-title":"Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression","volume":"12","author":"Di Donna","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2014.05.003_bib93","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1253\/circj.CJ-09-0140","article-title":"Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy. Results from Kochi Ryoma study","volume":"73","author":"Kubo","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2014.05.003_bib94","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.amjcard.2012.04.051","article-title":"Beta-blockers for prevention of exercise-induced left\u00a0ventricular outflow tract obstruction in hypertrophic cardiomyopathy","volume":"110","author":"Nistri","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib95","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib96","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib97","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.112.000849","article-title":"Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction","volume":"128","author":"Desai","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib98","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/01.CIR.0000162460.36735.71","article-title":"Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy","volume":"111","author":"Woo","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib99","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jacc.2011.08.040","article-title":"Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment","volume":"58","author":"Ball","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib100","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/eurheartj\/ehm117","article-title":"Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy","volume":"28","author":"McLeod","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.05.003_bib101","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.jacc.2011.06.073","article-title":"Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter north american registry","volume":"58","author":"Nagueh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib102","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.amjcard.2009.02.056","article-title":"Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"104","author":"Noseworthy","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib103","first-page":"362","article-title":"Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution","volume":"3","author":"ten Cate","year":"2010","journal-title":"Circ: Heart Fail"},{"key":"10.1016\/j.jacc.2014.05.003_bib104","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2009.09.047","article-title":"Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy","volume":"55","author":"Agarwal","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib105","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jacc.2008.07.061","article-title":"Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy","volume":"52","author":"Cuoco","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib106","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacc.2006.08.055","article-title":"Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy","volume":"49","author":"Valeti","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib107","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.jacc.2011.06.073","article-title":"Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy","volume":"58","author":"Nagueh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib108","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jacc.2007.05.018","article-title":"Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?","volume":"50","author":"Olivotto","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib109","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.amjcard.2013.09.041","article-title":"Long-term consequences of the right ventricular pacing mania of the 1990s for obstructive hypertrophic cardiomyopathy","volume":"113","author":"Maron","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib110","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/01.CIR.99.22.2927","article-title":"Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic\u00a0patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-Pathy)","volume":"99","author":"Maron","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib111","first-page":"A14979","article-title":"Progressive heart failure is uncommon in patients with nonobstructive hypertrophic cardiomyopathy","volume":"128","author":"Rowin","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib112","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.107.698985","article-title":"Evaluation of left ventricular filling pressures by\u00a0Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac\u00a0catheterization","volume":"116","author":"Geske","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.05.003_bib113","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2010.03.020","article-title":"Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"106","author":"Olivotto","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib114","first-page":"574","article-title":"Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy","volume":"3","author":"Maron","year":"2010","journal-title":"Circ: Heart Fail"},{"key":"10.1016\/j.jacc.2014.05.003_bib115","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.12.045","article-title":"Left\u00a0atrial\u00a0remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance","volume":"113","author":"Maron","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib116","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/CIRCEP.113.000339","article-title":"Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: long-term outcomes and mechanisms of arrhythmia recurrence","volume":"6","author":"Santangeli","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib117","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1540-8167.2008.01192.x","article-title":"Substrate and procedural predictors of outcomes\u00a0after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"19","author":"Bunch","year":"2008","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib118","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.jacc.2011.03.021","article-title":"Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy","volume":"57","author":"Maron","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.05.003_bib119","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.amjcard.2013.11.018","article-title":"Recognition of hypertrophic cardiomyopathy as a contemporary, relatively common and treatable disease: International Summit V","volume":"113","author":"Maron","year":"2014","journal-title":"Am J Cardiol"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2014.07.940","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:00:00Z","timestamp":1410825600000}}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714023390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714023390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T06:30:30Z","timestamp":1565591430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109714023390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0735109714023390"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2014.05.003","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jacc.2014.07.940","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2014.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}